Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyoscine Butylbromide for Labor Duration
NCT03441217Completed
- Sponsor
- Hospital Santo Tomás
- Start
- Jul 2019
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in labor comparing Hyoscine Butylbromide with Placebo (2 arms). Primary endpoints: Duration of first stage of labor at 24 hours and Rate of cervical dilation at 24 hours. Started Jul 2019; status: completed.
02
Drugs
hyoscine butylbromide
03
Conditions
labor
Beyond the preview
Go deeper on NCT03441217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03441217.